Navigation Links
Sangamo BioSciences Announces Presentation At The 2013 Wedbush Life Sciences Management Access Conference
Date:8/7/2013

RICHMOND, Calif., Aug. 7, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 9:10 am ET on Wednesday, August 14, 2013, at the 2013 Wedbush Life Sciences Management Access Conference which will be held in New York City.

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo
Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. The Company has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia, Huntington's disease and  hemoglobinopathies such as beta-thalassemia and sickle cell anemia. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene ex
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
2. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
3. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
4. Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast
5. Sangamo BioSciences Reports First Quarter 2012 Financial Results
6. Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences
7. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
8. Sangamo BioSciences Announces Second Quarter 2012 Conference Call and Webcast
9. Sangamo BioSciences Announces Presentation At The Stifel Nicolaus 2012 Healthcare Conference
10. Sangamo BioSciences Announces Presentation At The Lazard Capital Markets Healthcare Conference
11. Sangamo BioSciences Announces Fourth Quarter And Full Year 2012 Conference Call And Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Pfenex Inc. (NYSE ... the development of biosimilar therapeutics, today announced that ... Global Healthcare Conference in Miami, FL at the Loews Miami ... executive officer of Pfenex, will provide an overview ... on March 12th at 9:00 am ET. A live audio webcast ...
(Date:3/2/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... today announced that it will release fourth quarter and ... March 10, 2015 after the close of the U.S. ... and webcast on Tuesday, March 10, 2015 at 4:30 ... results and recent corporate developments. For both ...
(Date:3/2/2015)... 02, 2015 Global Stem ... alliance with Shenzhen HANK Bioengineering Co., Ltd. and ... alliance will establish a stem cells training course ... in September 2015. , Shenzhen HANK is a ... award-winning scientist, microbiologist and virologist, to integrate research, ...
(Date:2/28/2015)... Increasing its efforts to resolve the GMO Controversy ... of The GMO TRUTH podcast on both ITunes and at ... its mission to discover the truth and change the world. ... the truth about the GMOs in our food supply,” adds ... is an expansion of the documentary/investigative film-making methodology in place ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3The Walk a Mile Project Launches “GMO Truth” Podcast 2
... Studies show that up to 30% of coffees ordered as "decaf" contain ... the first do-it-yourself caffeine test strip from Silver Lake Research, the leader ... ... (PRWEB) November 12, 2008 -- Ever wonder whether the coffee you had ...
... Md., Nov. 12 MaxCyte, Inc.,the pioneer in ... will be hosting a live discussion with industry ... for drug discovery.,The discussion is open to the ... November 13th from 2:00-3:00EST., One of the ...
... 12 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc.,(TSX: SDI) today ... September 30, 2008., "In September, Spectral took ... strategy to align its diagnostic with a therapeutic ... Toray Industries Inc., to key,terms for the exclusive ...
Cached Biology Technology:Is Your Decaf Really Decaf? Use New "D+CAF (tm) Caffeine Test Strips" to Know for Sure 2MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery 2Spectral announces third quarter 2008 results 2Spectral announces third quarter 2008 results 3Spectral announces third quarter 2008 results 4Spectral announces third quarter 2008 results 5Spectral announces third quarter 2008 results 6Spectral announces third quarter 2008 results 7Spectral announces third quarter 2008 results 8
(Date:2/24/2015)... This report analyzes the worldwide markets for Face and Voice Biometrics ... Biometrics. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , Middle ... Latin America . Annual estimates and forecasts are provided ... is provided for these markets. Market data and analytics are derived ...
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/11/2015)... 2015 According to ... Market by Product (Cards and Readers, Biometrics, Controllers, Management ... Industrial, Healthcare, Education) and By Geography - Global Forecast and Analysis ... Access Control Market is expected to reach ... CAGR of 10.6% between 2014 and 2020. ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... December 13, 2010 The American Society for Cell ... Open Microscopy Environment (OME), today announce the launch of ... Meeting of the American Society for Cell Biology. In ... through the National Institutes of Health,s (NIH) Grand Opportunities ...
... Global health experts today published a landmark collection ... on the experience of countries, companies and organizations ... homegrown drugs, vaccines, diagnostics and other creative scientific ... chronicles the triumphs and troubles of entrepreneurs, institutes ...
... Research published today identifies two genetic variants that ... disease. The study provides clues to the origin of ... impact on the quality of life of sufferers. ... Wellcome Trust Centre for Human Genetics and the Nuffield ...
Cached Biology News:ASCB launches 'The Cell: An Image Library' to inspire discovery and improve human health 2Studies detail triumphs, troubles of African innovators creating products for local health needs 2Studies detail triumphs, troubles of African innovators creating products for local health needs 3Studies detail triumphs, troubles of African innovators creating products for local health needs 4Studies detail triumphs, troubles of African innovators creating products for local health needs 5Studies detail triumphs, troubles of African innovators creating products for local health needs 6Studies detail triumphs, troubles of African innovators creating products for local health needs 7Studies detail triumphs, troubles of African innovators creating products for local health needs 8Studies detail triumphs, troubles of African innovators creating products for local health needs 9Studies detail triumphs, troubles of African innovators creating products for local health needs 10Studies detail triumphs, troubles of African innovators creating products for local health needs 11Studies detail triumphs, troubles of African innovators creating products for local health needs 12Studies detail triumphs, troubles of African innovators creating products for local health needs 13Studies detail triumphs, troubles of African innovators creating products for local health needs 14Studies detail triumphs, troubles of African innovators creating products for local health needs 15Studies detail triumphs, troubles of African innovators creating products for local health needs 16Studies detail triumphs, troubles of African innovators creating products for local health needs 17Studies detail triumphs, troubles of African innovators creating products for local health needs 18Studies detail triumphs, troubles of African innovators creating products for local health needs 19Genetic variants linked to increased risk of common gynecological disease 2
RatTRAPTM Assay is a solid-phase immunofixed enzyme activity assay for the determination of osteoclast-derived TRACP 5b activity in rat serum....
Applications include ELISA, immunochemistry, and Western blotting. Working Concentrations: ELISA: 0.005-0.05 U/ml, immunohisto/cytochemistry: 0.25-0.5 U/ml, Western blot: 0.1-0.25 U/ml....
... Agarose Gel-Digesting Preparation contains a unique β-agarose ... quantitative recovery of intact DNA and RNA ... following electrophoresis in TAE, TBE, MOPS, or ... directly in the TAE, TBE, MOPS, and ...
Poly A Polymerase catalyzes the addition of AMP to the 3' hydroxyl terminus of RNA. Poly A Polymerase can add poly(C) and poly(U) to RNA but does so with much-reduced efficiency....
Biology Products: